The link between the use of inhaled corticosteroids (ICS) and pneumonia in people with COPD remains unclear, with conflicting data and no clear biological mechanisms, a respiratory insights forum held in Melbourne has been told. Speaking during a session called ‘ICS and pneumonia risk’ Professor Ian Yang, Director of Thoracic Medicine at The Prince Charles ...
Striking a balance between exacerbation prevention and pneumonia risk
Sponsored by A. Menarini Pty Ltd.
By Helen Signy
31 Aug 2016